PNG version of QUB Shield - Red

NICR_Logo_215W_84H

2017

Drummond FJ, Gavin AT, Sharp L. Supportive medications and interventions received by prostate cancer survivors: results from the PiCTure study. JCSO 2017; 15:e309-313. doi:10.12788/jcso.0384

Bannon F, Cairnduff V, Fitzpatrick D, Blaney J, Gomes B, Gavin A, Donnelly C. Insights into the factors associated with achieving the preference of home death in terminal cancer: A national population-based study. Palliat Support Care 2017; 23:1-7. doi:10.1017/S1478951517000876

Maguire R, Hanly P, Drummond FJ, Gavin A, Sharp L. Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors. Psychooncology 2017; 26:1825-1831. doi: 10.1002/pon.4384

Matheson L, Watson EK, Nayoan J, … , Gavin A, et al. A qualitative metasynthesis exploring the impact of prostate cancer and its management on younger, unpartnered and gay men. Eur J Cancer Care 2017; 26:e12676. doi:10.1111/ecc.12676

Keinan-Boker L, Silverman BG, Walsh PM, Gavin AT, Hayes C. Time trends in the incidence and mortality of ovarian cancer in Ireland, Northern Ireland, and Israel, 1994-2013. Int J Gynecol Cancer 2017; 27:1628-1636. doi:10.1097/IGC.0000000000001079

Morgan E, Drummond FJ, Coyle C, Sharp L, Gavin AT. Physical after-effects in men undergoing prostate biopsy in routine clinical practice: Results from the PiCTure study. Urol Oncol 2017; 35:604.e11-604.e16. doi:10.1016/j.urolonc.2017.06.003

Donnelly C, Quaife S, Forbes L, … , Gavin A. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study. Eur J Public Health 2017; 27:808-813. doi:10.1093/eurpub/ckx064 Implications of Research for Services download

Minicozzi P, Innos K, Sánchez M-J, Trama A, … , Gavin A, Fitzpatrick D, et al. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer 2017; 84:335-353. doi:10.1016/j.ejca.2017.07.015

Storm H, Engholm G, Mägi M, Aareleid T, … , Gavin A, Donnelly C, et al. Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer 2017; 82:137-148. doi:10.1016/j.ejca.2017.05.028

Donnelly C, Hart N, McCrorie AD, … , Gavin A. Knowledge or noise? Making sense of General Practitioners' and Consultant use of 2-week-wait referrals for suspected cancer. Br J Cancer 2017; 117:597-603. doi:10.1038/bjc.2017.213

Donnelly C, Cairnduff V, Chen JJ, Kearney T, Fitzpatrick D, Fox C, Gavin A. The completeness and timeliness of cancer registration and the implications for measuring cancer burden. Cancer Epidemiol 2017; 49:101-107. doi:10.1016/j.canep.2017.05.007

Gatta G, Capocaccia R, Botta L, Mallone S, … , Gavin A, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study. Lancet Oncol 2017; 18:1022-1039. doi: 10.1016/S1470-2045(17)30445-X

Gray RT, Loughrey MB, Bankhead P, Cardwell CR, … , Gavin AT, et al. Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study. Br J Cancer 2017; 116:1652-1659. doi:10.1038/bjc.2017.139

Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, ... , Gavin AT, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol 2017; 18:719-731. doi:10.1016/S1470-2045(17)30186-9

Donnelly CB, Wotherspoon AC, Morris M, Wilson RH, Chen JJ, Cairnduff V, Morgan E, Devlin A, Gavin AT. A population-level investigation of cancer clinical trials participation in a UK region. Eur J Cancer Prev 2017; 26:S229-S235. doi:10.1097/CEJ.0000000000000373 Implications of Research for Services download

Dal Maso L, Tavilla A, Pacini F, Serraino D, … , Gavin A, Donnelly C, et al. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017; 77:140-152. doi:10.1016/j.ejca.2017.02.023

Bonaventure A, Harewood R, Stiller CA, Gatta G, ... , Fitzpatrick D, Gavin A, et al. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.  Lancet Haematol 2017; 4:e202-e217. doi:10.1016/S2352-3026(17)30052-2

Roulston A, Campbell A, Cairnduff V, Fitzpatrick D, Donnelly C, Gavin A. Bereavement outcomes: A quantitative survey identifying risk factors in informal carers bereaved through cancer. Palliat Med 2017; 31:162-170. doi:10.1177/0269216316649127

Matz M, Coleman MP, Carreira H, Salmerón D, ... , Fitzpatrick D, Gavin A, et al. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol 2017; 44:396-404. doi:10.1016/j.ygyno.2016.11.019

Matz M, Coleman MP, Sant M, Chirlaque MD, ... , Fitzpatrick D, Gavin A, et al. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol 2017; 144:405-413. doi:10.1016/j.ygyno.2016.10.019.

Coyle C, Morgan E, Drummond FJ, Sharp L, Gavin A. Do men regret prostate biopsy: Results from the PiCTure study. BMC Urol 2017; 17:11. doi:10.1186/s12894-016-0194-y

Grey RT, Cantwell MM, Coleman HG, … , Gavin A, et al. Evaluation of PTGS2 expression, PIK3CA mutation, aspirin use and colon cancer survival in a population-based cohort study. Clin Transl Gastroenterol 2017; 8:e91. doi:10.1038/ctg.2017.18